StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | ITCI Intra-Cellular Therapies | $0.00 | — | $14.0B | — | 20.6 | +46.6% | 91.6% | 50 |
| 1 | BMY Bristol-Myers Squibb | $56.77 | +0.67% | $115.2B | 19.3 | 2.4 | +1.8% | 53.7% | 56 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $75.48 |
| +1.53% |
| $31.2B |
| 11.8 |
| 3.3 |
| +2.4% |
| 71.8% |
| 53 |
| 3 | PFE Pfizer | $25.75 | -0.81% | $146.6B | 19.6 | 2.3 | +1.4% | 74.8% | 41 |
| 4 | AXSM Axsome Therapeutics | $232.27 | -1.30% | $12.0B | — | 16.9 | +63.9% | 92.6% | 39 |
| 5 | VTRS Viatris | $17.26 | -0.63% | $20.2B | — | 1.4 | +1.6% | 39.8% | 32 |
| 6 | RPRX RPRX | $53.40 | +0.28% | $30.7B | 37.1 | 12.6 | +7.8% | — | — |
| 7 | ELAN ELAN | $21.64 | -0.73% | $10.9B | — | 2.2 | +10.5% | 55.1% | — |
| 8 | CORT CORT | $58.30 | +2.14% | $6.3B | 132.9 | 8.2 | +12.2% | 98.3% | — |
| 9 | BLTE BLTE | $149.95 | -2.33% | $6.2B | — | — | — | — | — |